Dual Inhibition of SGLT1 and 2 with Sotagliflozin– a Novel Approach to Maximize Cardiorenal Protection in Type 1 Diabetes.

Project Details

StatusActive
Effective start/end date1/01/2331/07/24

Funding

  • Diabetes Research Foundation of WA: A$60,000.00